Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | FHIT | P49789 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3662214 | 0.86 | GAA (0.57) | GAAMAPK1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL3106813 | 0.84 | GAA (0.45) | GAAMAPK1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL3718737 | 0.77 | ALDH1A1 (0.52) | GAAMAPK1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL13160409 | 0.77 | GAA (0.46) | GAAMAPK1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL3663510 | 0.76 | GAA (0.46) | GAAMAPK1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL2775462 | 0.74 | ALDH1A1 (0.51) | GAAMAPK1ALDH1A1MAPTHSD17B10 | |
| SCHEMBL1973680 | 0.74 | GAA (1.00) | GAAMAPK1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL69313 | 0.74 | GAA (0.71) | GAAMAPK1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL3662027 | 0.73 | ADORA1 (0.46) | GAAMAPK1ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL3663286 | 0.73 | SMN1; SMN2 (0.54) | GAAMAPK1ALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9221787-B2 | Sulphonamine compounds and methods of making and using same | ZAFGEN, INC. (US) | 2015-12-29 | — | — | US | disclosed |
| US-9221787-B2 | Sulphonamine compounds and methods of making and using same | ZAFGEN, INC. (US) | 2015-12-29 | — | — | US | disclosed |
| US-20130217759-A1 | Sulphonamine Compounds and Methods of Making and Using Same | ZAFGEN INC. (US) | 2013-08-22 | — | — | US | disclosed |
| US-20130217759-A1 | Sulphonamine Compounds and Methods of Making and Using Same | ZAFGEN INC. (US) | 2013-08-22 | — | — | US | disclosed |
| EP-2627632-A1 | SULPHONAMIDE COMPOUNDS AND METHODS OF MAKING AND USING SAME | Zafgen, Inc. (US) | 2013-08-21 | — | — | EP | disclosed |
| US-8362008-B2 | Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors | THE UNIVERSITY OF EDINBURGH (GB) | 2013-01-29 | — | — | US | disclosed |
| US-8362008-B2 | Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors | THE UNIVERSITY OF EDINBURGH (GB) | 2013-01-29 | — | — | US | disclosed |
| US-8362008-B2 | Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors | THE UNIVERSITY OF EDINBURGH (GB) | 2013-01-29 | — | — | US | disclosed |
| WO-2012051318-A1 | SULPHONAMIDE COMPOUNDS AND METHODS OF MAKING AND USING SAME | ZAFGEN CORPORATION (US) | 2012-04-19 | — | — | WO | disclosed |
| US-20100267696-A1 | Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors | THE UNIVERSITY OF EDINBURGH | 2010-10-21 | — | — | US | disclosed |
| US-20100267696-A1 | Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors | THE UNIVERSITY OF EDINBURGH | 2010-10-21 | — | — | US | disclosed |
| US-20100267696-A1 | Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors | THE UNIVERSITY OF EDINBURGH | 2010-10-21 | — | — | US | disclosed |
| EP-2229374-A1 | AMIDO-THIOPHENE COMPOUNDS AND THEIR USE AS 11-BETA-HSD1 INHIBITORS | THE UNIVERSITY OF EDINBURGH (GB) | 2010-09-22 | — | — | EP | disclosed |
| WO-2009074789-A1 | AMIDO-THIOPHENE COMPOUNDS AND THEIR USE AS 11-BETA-HSD1 INHIBITORS | THE UNIVERSITY OF EDINBURGH (GB) | 2009-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267696-A1 | Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors | HSD11B1, HSD11B2, HSD17B1 | GAA 959/4885MAPK1 477/4885ALDH1A1 285/4885 |
| US-20130217759-A1 | Sulphonamine Compounds and Methods of Making and Using Same | DNPEP, METAP2, ANPEP | GAA 93/4885MAPK1 4195/4885ALDH1A1 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.